This stock is very close to its usual long term low.  This utility tends to bottom as the market is topping.  He does not think it has stopped falling yet and thinks it has another 8-10% downside yet to go.  He would suggest holding if you already have it.  

The company reached a big target at 10 times book value near $120.  The problem is that its intrinsic value, based on earnings growth, is about 30% lower than the current stock price.  It the market has a pullback, this could pull back to at least $93.  

A managed care provider in the US.  He thinks the stock still have 22% upside and the earnings are rising.  The bad news is it is trading at 2.5 times book value, when a few years ago it traded at book value.  He likes the sector and in the long term this should be fine.  

In light of Stronach suing his daughter, this is an interesting stock. Recently they reached 2 times book value – an extended valuation given how late we are in the business cycle. If the stock dropped another $6 it would be back to fair value.

He sees it at $4.50 earnings per share – trading at 27 times earnings.   It has traded back to $156, his target, and would see it as a buy. (Analysts’ price target is $220)

If they sell some assets, it would help the balance sheet, he thinks.  The company is paying out almost twice what it is earning.  The results in the balance sheet melting away.  They would do an enormous service to cut the dividend to a sustainable yield, like 5%. 

The dividend is definitely sustainable. They are paying out less than half their earnings. They had some mortgage issues in the past, but the stock price is at a very attractive level.  Yield 6.3%.